The deubiquitinase USP9X regulates FBW7 stability and suppresses colorectal cancer

The tumor suppressor FBW7 targets oncoproteins such as c-MYC for ubiquitylation and is mutated in several human cancers. We noted that in a substantial percentage of colon cancers, FBW7 protein is undetectable despite the presence of FBW7 mRNA. To understand the molecular mechanism of FBW7 regulation in these cancers, we employed proteomics and identified the deubiquitinase (DUB) USP9X as an FBW7 interactor. USP9X antagonized FBW7 ubiquitylation, and Usp9x deletion caused Fbw7 destabilization. Mice lacking Usp9x in the gut showed reduced secretory cell differentiation and increased progenitor proliferation, phenocopying Fbw7 loss. In addition, Usp9x inactivation impaired intestinal regeneration and increased tumor burden in colitis-associated intestinal cancer. c-Myc heterozygosity abrogated increased progenitor proliferation and tumor burden in Usp9x-deficient mice, suggesting that Usp9x suppresses tumor formation by regulating Fbw7 protein stability and thereby reducing c-Myc. Thus, we identify a tumor suppressor mechanism in the mammalian intestine that arises from the posttranslational regulation of FBW7 by USP9X independent of somatic FBW7 mutations.

[1]  Andrew J. Dunford,et al.  Tumor suppressor genes that escape from X-inactivation contribute to cancer sex bias , 2016, Nature Genetics.

[2]  S. Gabriel,et al.  Erratum: Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma (Cell Reports (2016) 15(4) (857–865) (S2211124716303643) (10.1016/j.celrep.2016.03.075)) , 2016 .

[3]  Eric S. Lander,et al.  Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma , 2016, Cell reports.

[4]  Zachary J. Heins,et al.  Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease. , 2016, Gastroenterology.

[5]  Zhaojian Liu,et al.  Ubiquitin-specific protease 22 is a deubiquitinase of CCNB1 , 2015, Cell Discovery.

[6]  M. Eilers,et al.  Usp28 counteracts Fbw7 in intestinal homeostasis and cancer. , 2015, Cancer research.

[7]  M. Eilers,et al.  Dual regulation of Fbw7 function and oncogenic transformation by Usp28. , 2014, Cell reports.

[8]  A. Ferrando,et al.  The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability , 2013, Cell.

[9]  I. Tomlinson,et al.  Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines , 2013, Gut.

[10]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[11]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[12]  J. Decaprio,et al.  Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase. , 2012, Molecular cell.

[13]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[14]  G. Kristiansen,et al.  The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma , 2012, Nature.

[15]  T. Kietzmann,et al.  GSK-3β regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1α. , 2012, Blood.

[16]  B. Spencer‐Dene,et al.  The F-box protein Fbw7 is required for cerebellar development. , 2011, Developmental biology.

[17]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[18]  Akinobu Matsumoto,et al.  Fbxw7β resides in the endoplasmic reticulum membrane and protects cells from oxidative stress , 2011, Cancer science.

[19]  B. Spencer‐Dene,et al.  FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation , 2011, The Journal of experimental medicine.

[20]  A. Behrens,et al.  c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex , 2011, Nature.

[21]  Akinobu Matsumoto,et al.  Fbxw7 regulates lipid metabolism and cell fate decisions in the mouse liver. , 2011, The Journal of clinical investigation.

[22]  I. Tomlinson,et al.  F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor. , 2010, Gastroenterology.

[23]  F. Bazan,et al.  Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival , 2010, Nature.

[24]  David Komander,et al.  Breaking the chains: structure and function of the deubiquitinases , 2009, Nature Reviews Molecular Cell Biology.

[25]  B. Spencer‐Dene,et al.  JNK signalling modulates intestinal homeostasis and tumourigenesis in mice , 2009, The EMBO journal.

[26]  I. Voutsadakis.  The ubiquitin-proteasome system in colorectal cancer. , 2008, Biochimica et biophysica acta.

[27]  Hans Clevers,et al.  Loss of intestinal crypt progenitor cells owing to inactivation of both Notch1 and Notch2 is accompanied by derepression of CDK inhibitors p27Kip1 and p57Kip2 , 2008, EMBO reports.

[28]  Xi C. He,et al.  Current view: intestinal stem cells and signaling. , 2008, Gastroenterology.

[29]  B. Clurman,et al.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation , 2008, Nature Reviews Cancer.

[30]  M. Eilers,et al.  Fbw7 and Usp28 Regulate Myc Protein Stability in Response to DNA Damage , 2007, Cell cycle.

[31]  Julie A. Wilkins,et al.  Myc deletion rescues Apc deficiency in the small intestine , 2007, Nature.

[32]  P. McPherson,et al.  The Ubiquitin Ligase Itch Is Auto-ubiquitylated in Vivo and in Vitro but Is Protected from Degradation by Interacting with the Deubiquitylating Enzyme FAM/USP9X* , 2006, Journal of Biological Chemistry.

[33]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[34]  S. Artavanis-Tsakonas,et al.  Notch signals control the fate of immature progenitor cells in the intestine , 2005, Nature.

[35]  Takuji Tanaka,et al.  β‐Catenin mutations in a mouse model of inflammation‐related colon carcinogenesis induced by 1,2‐dimethylhydrazine and dextran sodium sulfate , 2005, Cancer science.

[36]  Allan Balmain,et al.  Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene , 2004, Nature.

[37]  Daniel Metzger,et al.  Tissue‐specific and inducible Cre‐mediated recombination in the gut epithelium , 2004, Genesis.

[38]  A. Behrens,et al.  The Ubiquitin Ligase SCFFbw7 Antagonizes Apoptotic JNK Signaling , 2004, Science.

[39]  S. Elledge,et al.  Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin Ligase , 2001, Science.

[40]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[41]  A. Moser,et al.  Loss of Apc+ in intestinal adenomas from Min mice. , 1994, Cancer research.

[42]  H. Adami,et al.  Ulcerative colitis and colorectal cancer. A population-based study. , 1990, The New England journal of medicine.

[43]  H. Adami,et al.  Increased risk of large-bowel cancer in Crohn's disease with colonic involvement , 1990, The Lancet.

[44]  G. Kristiansen,et al.  The deubiquitinase USP 9 X suppresses pancreatic ductal adenocarcinoma , 2012 .

[45]  W. de Lau,et al.  WNT signaling in the normal intestine and colorectal cancer. , 2007, Frontiers in bioscience : a journal and virtual library.

[46]  H. Clevers.  Wnt/beta-catenin signaling in development and disease. , 2006, Cell.